Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression

Journal of ECT

Volumn 22, Issue 3, 2006, Pages 218-222

  Burke, Michael J ^a   Husain, Mustafa M ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antidepressant treatment; Brain stimulation; Depression; Electroconvulsive therapy; Major depressive disorder; Treatment resistant depression; Vagus nerve stimulation

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; SUICIDE ATTEMPT; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGUS NERVE STIMULATION;

ADULT; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG RESISTANCE; ELECTRIC STIMULATION THERAPY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VAGUS NERVE;

EID: 33748598720     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/01.yct.0000230364.04240.52     Document Type: Article

References (31)

1. Szanto K, Mulsant BH, Houck PR, et al. Treatment outcome in suicidal vs. non-suicidal elderly patients. Am J Geriatr Psychiatry. 2001;9:261-268.
2. Rifai AH, George CJ, Stack JA, et al. Hopelessness in suicide attempters after acute treatment of major depression in late life. Am J Psychiatry. 1994;151:1687-1690.
3. Moos RH, Cronkite RC. Symptom-based predictors of a 10-year chronic course of treated depression. J Nerv Ment Dis. 1999;187:360-368.
4. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry. 2002;63:963-971.
5. Russell JM, Hawkins K, Ozminkowski RJ, et al. The cost consequences of treatment-resistant depression. J Clin Psychiatry. 2004;65:341-347.
6. Trivedi MH, Rush AJ, Crismon ML, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004;61:669-680.
7. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157:1-45.
8. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153:985-992.
9. Lisanby SH. Brain Stimulation in Psychiatric Treatment. Washington, DC: American Psychiatric Publishing; 2004.
10. Harden CL, Pulver MC, Ravdin LD, et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 2000;1:93-99.
11. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 2000;47:276-286.
12. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713-728.
13. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002;51:280-287.
14. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005;58:347-354.
15. Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2005;58:355-363.
16. George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry. 2005;58:364-373.
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
18. Rush AJ, Gullion CM, Basco MR, et al. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477-486.
19. Physician's Manual. VNS Therapy™ Pulse Model 102 Generator and VNS Therapyi Pulse Duo Model 102R Generator. Available at: http://www.vnstherapy. com/manuals/doc_download.asp?docid={E5D2100B-A4C2-409B-B71C-E1CEA60FBD90}. Accessed October 27, 2005.
20. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62:11-17.
21. Giltay EJ, Kho KH, Keijzer LT, et al. Electroconvulsive therapy (ECT) in a patient with a dual-chamber sensing, VDDR pacemaker. J ECT. 2005;21:35-38.
22. Dolenc TJ, Barnes RD, Hayes DL, et al. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004;27:1257-1263.
23. Husain MM, Montgomery JH, Fernandes P, et al. Safety of vagus nerve stimulation with ECT. Am J Psychiatry. 2002;159:1243.
24. Lapid MI, Rummans TA, Hofmann VE, et al. ECT and automatic internal cardioverter-defibrillator. J ECT. 2001;17:146-148.
25. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57:425-434.
26. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10:96-104.
27. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299-1307.
28. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990;31:287-296.
29. Vaidya NA, Mahableshwarkar AR, Shahid R. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT. 2003;19:10-16.
30. Russell JC, Rasmussen KG, O'Connor MK, et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT. 2003;19:4-9.
31. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005;66:1097-1104.